OrganiGram Holdings Operating Expenses 2011-2026 | OGI

Annual Operating Expenses OrganiGram Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	41.4 M	42.4 M	16.1 M	8.04 M	4.07 M	9.35 M	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
42.4 M	4.07 M	20.2 M

Operating Expenses of other stocks in the Drug manufacturers industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Zynerba Pharmaceuticals ZYNE	35.3 M	-	-	$ 55.5 M	USA
Alimera Sciences ALIM	71.8 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	38.9 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	213 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	197 M	$ 1.2	0.42 %	$ 129 M	Canada
AcelRx Pharmaceuticals ACRX	40.3 M	-	7.5 %	$ 6.35 M	USA
Cronos Group CRON	154 M	$ 2.69	-0.56 %	$ 1.42 B	Canada
Agile Therapeutics AGRX	30.5 M	-	10.11 %	$ 58.2 M	USA
Catalent CTLT	512 M	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	44.6 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	113 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	763 M	-	-	$ 28.9 M	Irlanda
Calliditas Therapeutics AB (publ) CALT	213 M	-	-0.1 %	$ 2.03 B	Schweden
Evoke Pharma EVOK	12.6 M	-	-	$ 36.6 M	USA
HEXO Corp. HEXO	106 M	-	2.45 %	$ 38.1 M	Canada
Emergent BioSolutions EBS	558 M	$ 12.84	2.8 %	$ 657 M	USA
Athenex ATNX	96.7 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	196 M	$ 21.5	-0.12 %	$ 2.05 B	France
Evolus EOLS	107 M	$ 6.03	-10.27 %	$ 374 M	USA
Harrow Health HROW	90.1 M	$ 54.06	8.3 %	$ 1.76 B	USA
Jupiter Wellness JUPW	39.6 M	-	-	$ 33.6 M	USA
China Pharma Holdings CPHI	2.6 M	$ 1.23	1.65 %	$ 21.5 M	China
Bausch Health Companies BHC	4.96 B	$ 7.51	4.16 %	$ 2.74 B	Canada
Lannett Company LCI	209 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	55.6 M	-	-	$ 193 M	Canada
Cumberland Pharmaceuticals CPIX	35.2 M	$ 3.95	-0.77 %	$ 55.5 M	USA
Organogenesis Holdings ORGO	368 M	$ 4.36	-5.93 %	$ 574 M	USA
Sundial Growers SNDL	102 K	$ 1.72	-1.41 %	$ 3.37 M	Canada
Pacira BioSciences PCRX	279 M	$ 25.21	3.07 %	$ 1.17 B	USA
Sonoma Pharmaceuticals SNOA	9.18 M	$ 3.73	2.46 %	$ 4.63 M	USA
Aurora Cannabis ACB	183 M	$ 4.28	-1.41 %	$ 86.3 M	Canada
Rockwell Medical RMTI	31.1 M	$ 0.98	13.92 %	$ 22.9 M	USA
PetIQ PETQ	138 M	-	1.64 %	$ 400 M	USA
Perrigo Company plc PRGO	1.43 B	$ 14.36	3.42 %	$ 1.97 B	USA
ProPhase Labs PRPH	47.1 M	-	-	$ 5.07 M	USA
Veru VERU	44 M	$ 2.28	0.58 %	$ 308 M	USA
Radius Health RDUS	304 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	22.5 M	-	-4.76 %	$ 65.3 M	USA
cbdMD YCBD	28.9 M	$ 1.11	-4.31 %	$ 4.79 M	USA
Relmada Therapeutics RLMD	104 M	$ 4.11	-6.06 %	$ 124 M	USA
OptiNose OPTN	129 M	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	133 M	$ 9.62	5.25 %	$ 683 M	USA
PLx Pharma PLXP	44.2 M	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	130 M	$ 5.33	-2.14 %	$ 218 M	USA
SCYNEXIS SCYX	67.5 M	$ 0.64	-0.03 %	$ 30.6 M	USA
Tricida TCDA	153 M	-	-	$ 3.25 M	USA
Tilray TLRY	1.52 B	$ 9.43	-3.03 %	$ 5.83 B	Canada
TherapeuticsMD TXMD	9.82 M	$ 1.79	8.78 %	$ 18.7 M	USA
Zomedica Corp. ZOM	14.1 M	-	-0.21 %	$ 98 M	USA